Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.
Share with a colleague
Pharmaceutical Executive Europe  E-News
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecutive
 
 
Survey
We asked 40 leaders, Is the pharma supply chain more secure than it was five years ago?
Yes 26%

No

8%
No change 66%
 

Talk to us:
jupton@advanstar.com

Advertise with us:
wblow@advanstar.com

25 June, 2014
Desperate Measures: Industry Teams with Parallel Traders to Tackle Counterfeiters in Europe
An improbable cross-sector partnership is struggling to secure support for a pan-European system to keep counterfeits out. It’s improbable because it brings together not only manufacturers, wholesalers, and pharmacists, but also parallel traders — long treated by drug manufacturers as pariahs and even downright enemies...Read more
The Social Media Questions Pharma Companies Should be Asking
For pharma companies, entering the social media scene is not as simple as just creating a Facebook page or learning how to tweet in 140 characters or less. Social media poses a regulatory and litigation maze that must be carefully navigated. Here, Mathew dos Santos and Lori Leskin provide some insight into the most pressing questions companies are, or should be, asking about social media ... Read more
Three Challenges to the Specialty Business Model
Drug discovery companies have progressively tailored their pipelines to specialty therapeutic areas and smaller patient populations. However, the specialty business model has lately shown signs of strain and outright constraints in continued scalability. Emily O’Connor, Jillian Scaife, and Ryan P. Million outline three key challenges to the focus on specialty indications that are particularly critical for drug companies ... Read more
Pharm Exec’s Top 50 Pharma Companies
The vigorous return of M&A activity to biopharmaceuticals this year begs the question: is more size and scalable efficiencies the best solution to the declining market power of pharmaceuticals in an endlessly restructuring healthcare system? Our latest annual iteration of the Pharma 50 rankings confirms that the answer to this is ‘no’... Read more
Product Cycle Strategies for Greater Profitability
In this compilation of four in-depth, data-rich reports from Pharmaceutical Executive, you'll learn a new set of metrics allowing companies to align their strategies around the push for greater profitability, putting them on the right track ... Click here to order
Also in this issue
Read the Latest Pharma Exec Global Digest: Transparency Special
Pharma Leads the Way in M&A
US Regulatory Agencies and Industry Bodies in Global Expansion Push
Pharm Exec eBooks Available as Apps